Robert L Ferris

66PUBLICATIONS
365CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursGene and molecular therapyOther biomedical and clinical sciences not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (66)

|Jul 15, 2026
Tim-3 Sustains Tumor Treg Stability and Function, Limiting Checkpoint Blockade Therapy Efficacy.

|Jul 13, 2026
Toward a Better Paradigm for Head and Neck Cancer Treatment Applying AI (HNC-TACTIC): Protocol for an International Cohort Study of Electronic Health Records.

|Jun 25, 2026
Tumoral and Systemic Immune Correlates of Response to Concurrent Pembrolizumab and Chemoradiotherapy in Patients with Resected High-Risk Head and Neck Squamous Cell Carcinoma.

|Jun 05, 2026
ATR kinase inhibitors induce mitochondrial fission in CD8<sup>+</sup> T cells and impair immune memory <i>in vivo</i>.

|Apr 01, 2026
Development of a Clinical Assay to Guide Patient Therapy in HPV-Associated Head and Neck Cancer.

Sri Vemulamanda, Aditi Kothari, Loris De Cecco

|Mar 05, 2026
Preexisting TCR Clones Drive Major Pathologic Responses in Patients with HNSCC Treated with Dual Immune Checkpoint Inhibitors.

Huaibin Ge, Housaiyin Li, Aditi Kulkarni

Pageof 11

Frequent Collaborators

8 joint publications

Daniel Zandberg

7 joint publications

Nabil F Saba

6 joint publications

Robert I Haddad

6 joint publications

Lazar Vujanovic